Involvement of dopamine D2 receptor signal transduction in the discriminative stimulus effects of the κ-opioid receptor agonist U-50,488H in rats

Behav Pharmacol. 2013 Aug;24(4):275-81. doi: 10.1097/FBP.0b013e3283635f6b.

Abstract

We have reported previously that the inhibition of both dopaminergic and psychotomimetic/hallucinogenic components plays a role in the discriminative stimulus effects of U-50,488H. However, the mechanisms that underlie the discriminative stimulus effects of U-50,488H, and especially the component that plays a significant role, have not yet been clarified. The present study was designed to further investigate the mechanism(s) of the discriminative stimulus effects of the κ-opioid receptor agonist U-50,488H in rats that had been trained to discriminate between 3.0 mg/kg U-50,488H and saline. The dopamine D2 receptor antagonist sulpiride, but not the D1 receptor antagonist SCH23390, generalized to the discriminative stimulus effects of U-50,488H. The mood-stabilizing agents lithium chloride and valproic acid, which have attenuating effects on the Akt/GSK3 pathway, also partially generalized to the discriminative stimulus effects of U-50,488H. In contrast, the 5-HT-related compound racemic 3,4-methylenedioxymethamphetamine, the cannabinoid receptor agonist WIN55,212-2, and the μ-opioid receptor agonist morphine failed to generalize to the discriminative stimulus effects of U-50,488H. These results suggest that the inhibition of the dopaminergic activity mediated by the postsynaptic D2 receptor, followed by suppression of the Akt/GSK3 pathway may be critical for the induction of the discriminative stimulus effects induced by U-50,488H.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer / pharmacology*
  • Adrenergic Uptake Inhibitors / pharmacology
  • Analgesics, Non-Narcotic / pharmacology*
  • Animals
  • Antimanic Agents / pharmacology
  • Conditioning, Operant / drug effects
  • Discrimination, Psychological / drug effects*
  • Dopamine Agents / pharmacology
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Lithium Chloride / pharmacology
  • Male
  • Morphine / pharmacology
  • N-Methyl-3,4-methylenedioxyamphetamine / pharmacology
  • Narcotics / pharmacology
  • Rats
  • Rats, Inbred F344
  • Receptors, Dopamine D2 / metabolism*
  • Signal Transduction / drug effects*

Substances

  • Adrenergic Uptake Inhibitors
  • Analgesics, Non-Narcotic
  • Antimanic Agents
  • Dopamine Agents
  • Narcotics
  • Receptors, Dopamine D2
  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
  • Morphine
  • Lithium Chloride
  • N-Methyl-3,4-methylenedioxyamphetamine